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Treatments used in cancer of the oral cavity have great impact on the physical, psychological and functional state 
of patients. There has been increasingly interest in evaluating the health-related quality of life using question-
naires among patients treated FOR oral cancer. Up to our knowledge no review on this theme has incorporated the 
level of evidence of the single identified studies. The objective of the present study is to determinate results and 
conclusions about the health-related quality of life of these patients, in view of scientific evidence. In general, the 
diversity of designs, level of evidence and questionnaires used for their assessment does not affect results, which 
indicate a decline in the health-related quality of life after treatment. This decline is greater when the tumor is 
large in size, and when radiotherapy is used, though the situation is seen to improve over the span of a year. Ques-
tionnaires on health-related quality of life provide concrete information regarding the impact of cancer treatment 
on patients.




Cancer of the oral cavity is a pathology of increasing 
significance worldwide. The approximately 263,000 
new cases every year make it the most common form of 
head/neck cancer; mortality rates indicate that over half 
of these cases survive (127,654 deaths per year) (1). Such 
figures indicate that a considerable number of patients 
cope with the after-effects of the treatment: surgery or 
the habitual combination of surgery, radiotherapy and 
chemotherapy.
A patient endures stressful situations from the diagno-
sis of oral cancer. In advanced stages, and after treat-
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ment, changes associated with chewing, swallowing, 
salivating and speech are seen (2,3). Thus, the patient s´ 
health-related quality of life (HRQoL) may be altered 
considerably. 
For these reasons, there is growing interest in evaluating 
the HRQoL using questionnaires among patients treat-
ed for oral cancer (4,5). The patient completed question-
naires are the most common method used to assess the 
HRQoL (2). They are composed for questions or items 
whose answers can be analyzed independently and be 
combined to obtain different domains (6).
The development of a hierarchy in the scientific evi-
dence has allowed health professionals to do an evi-
dence-based clinical practice (7). Up to our knowledge 
no review on HRQoL in patients treated FOR oral can-
cer has incorporated the level of evidence of the single 
identified studies. The aim of our study was to determi-
nate results/conclusions about HRQoL drawn by studies 
of patients treated for oral cancer, and to identify pos-
sible differences according to the study design or level 
of scientific evidence.
Material and Methods
A bibliographic search was done using MEDLINE and 
Scopus databases, with the strategy (“oral cancer” OR 
“mouth neoplasms”) AND “quality of life” AND “ques-
tionnaire” in the period 1966-Dic 2012. Quality of life 
was used as the main search term, as it is a more common 
keyword than HRQoL (8). Furthermore, studies included 
in the bibliographic references of these papers were iden-
tified. After this initial search, the abstracts were read 
and the full paper if necessary, in light of the inclusion 
criteria in this study. The articles were included if they 
assessed the HRQoL, psychological aspects and/or func-
tional aspects of patients treated for cancer of the oral 
cavity, oral and lip cancer, and/or oropharyngeal cancer, 
using a HRQoL questionnaire. The studies that incorpo-
rated other head neck cancers (nasal cavity, nasophar-
ynx, larynx…) were excluded. This process resulted in 
79 articles, referring to 62 independent studies. 
After that, the documents were classified according to 
their design as: 
-Randomized clinical trials: randomized intervention 
studies where, after applying different treatments in 
cancer patients, the results are compared using HRQoL 
questionnaires.
-Studies of controlled cohorts: those evaluating the 
quality of life of the patients on one occasion (without 
repeated measurements) or on numerous occasions (lon-
gitudinal study), the results being compared with those 
of a control cohort or with populational data existing in 
the literature. 
-Studies of non-controlled cohorts: longitudinal studies 
whose results were not contrasted with any other co-
hort.
-Transversal studies: those taking one measurement of 
the quality of life of patients without comparing results 
with any other cohort.
-Reviews: articles that offer an updated overview of the 
findings of previous studies.
Furthermore, the designs were coded according to the fol-
lowing levels of scientific evidence (9): 1 ++) Systematic 
review or meta-analysis of randomized clinical studies of 
a high quality or randomized clinical studies with a very 
low risk of bias. 1 +) Systematic review or meta-analysis 
of randomized clinical trials that were well conducted or 
randomized clinical trials with a low risk of bias. 1 –) 
Systematic review or meta-analysis of randomized clini-
cal trials, or randomized clinical trials with a high risk of 
bias. 2 ++) Systematic review of cohort studies or case 
controls of high quality, or systematic review of cohort 
studies or case controls of high quality and entailing a 
low risk of confounding factors, bias or chance, and a 
high probability of causal association. 2 +) Studies of co-
horts or case controls that were well conducted, with a 
low level of confounding factors, bias, chance and a mod-
erate probability of causal association. 2  –) Studies of 
cohorts or case controls with a high level of confounding 
factors, bias, chance and a significant risk that the asso-
ciation was not causal. 3) Non-analytical studies, such as 
cross-sectional surveys or case series. 4) Expert opinions 
or non-systematic reviews. 
No article selected for our study was excluded for meth-
odological reasons (10,11). The authors summed up the 
main results and conclusions from the articles included 
under the different types of study designs. To achieve 
final consensus, a focal group was organized consisting 
of the authors of this article and following the Europe-
Aid Evaluation Guidelines (12). Briefly, a focal group 
is a qualitative research technique that involves moder-
ated meetings in the form of a structured, open group 
interview. After exposition and discussion of the dif-
ferent opinions, a final report was written up with the 
results and conclusions agreed upon. 
Results
Table 1 shows the results of the bibliographic search 
conducted. There was an increase in the number of pub-
lications over time. We found that the general question-
naires were used in most often (European Organization 
for Research and Treatment of Cancer Quality of Life 
Questionnaires, EORTC-QLQ, closely followed by Uni-
versity of Washington Quality of Life Questionnaire, 
UW-QOL). Only four studies used the oral health im-
pact profile (OHIP), a specific questionnaire for assess-
ing changes in the oral health-related quality of life.
The main results and conclusions from the articles are 
presented according to their design in the table 2. Only 
2 experimental studies were found: one study classified 
as 1 ++ (maximum level of evidence), and another with 
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a level 1 +. There were 10 controlled cohort studies, with 
a 2 + level of evidence, whose results were not conclu-
sive. The 29 studies of non-controlled cohorts together 
with the 34 cross-sectional studies (level of scientific 
evidence 3) plus the 4 reviews found (level of evidence 
4) make manifest that the patients treated with radio-
therapy have a poorer HRQoL. 
Discussion
Quality of life has been considered to be an important 
outcome parameter in oral cancer (8), which explains 
the increasing number of studies on HRQoL found over 
the time period analyzed here. There is great diversity 
in the questionnaires used, or even combined, perhaps 
due to the fact that the concept of HRQoL is associated 
with multiple functional and psychosocial factors. The 
existence of a gold standard with unified criteria would 
allow the studies to be compared in a more rigorous 
manner. Overall, however, they do manage to cover the 
most common problems in a structured way, proving to 
be a useful tool for enhancing communication between 
health professionals and patients, which is essential in 
the area of cancer (6,13). 
Despite the heterogeneity of the designs, the results/
conclusions are on the same line: a decrease in the HR-
QoL after treatment (14-22), which appears to parallel 
the magnitude of the tumor (2,4,23-31), and the use of 
radiotherapy (2,4,5,29,32-40). After a year, this declin-
ing trend turns around (15,16,18,20,22,41-47). The im-
provement in HRQoL over time is a result to be taken 
with some caution. Coping mechanisms, or adaptation 
to a new situation, may be one reason, but we must not 
forget that the data are based on surviving patients with-
out relapse.
The existence of two randomized clinical trials evidences 
the practicality of incorporating the measure of HRQoL 
in these types of studies. Accordingly, HRQOL would 
have sufficient scientific backing to become a key consid-
eration in the treatment planning process, as in situations 
where there are virtually no differences in associated 
survival rates (48). Moreover, we should underline the 
lack of studies with controlled cohorts. The most of them 
compare the results of the patients with populational data 
or with the results of their partners/spouses whose life 
quality is likewise affected by the illness (3,49). It would 
be interesting to carry out new research studies designed 
in such a fashion that each patient would have a control 
paired up by age and sex that would allow for comparison 
of results in a less biased way. 
Despite therapeutic advances and enhanced survival, 
oral cancer patients inevitably face some decrease in 
HRQoL (28,50). They are not always satisfied with 
the information received, especially in relation to 
the changes they experience in their lifestyle after 
treatment(51,52). Health professionals have a variety 
of validated questionnaires, allowing them to familiar-
ize themselves with the after-effects of oral cancer and 
therapy to the improvement of this communication. On-
line questionnaires can be used to overcome the lack of 
time and resources of health professionals dealing with 
these patients (53). 
In conclusion, the diversity of study designs (level of 
evidence) does not appear to affect the results of stud-
ies. Construction of a standard questionnaire and its use 
in studies with a high scientific level of evidence would 
help make the differences found in the HRQoL become 
an important element in planning treatment for patients 
with oral cancer.  
Table 1. Summary of the bibliographic search.
a Review articles not included. The sum of the articles of this 
section is not equal the total of articles found because some 
of them combine questionnaires listed in the table.
b EORTC-QLQ: European Organization for Research and 
Treatment of Cancer Quality of Life Questionnaires.
c UW-QOL: the University of Washington Quality of Life.
d PSS-HN: the Head and Neck Performance Status Scale.
e SF-36: Medical Outcomes Study Short Form 36-item Health 
Survey.
f OHIP: Oral health impact profile.
g Studies not using EORTC, UW-QOL, PSS-HN, SF-36, or 
OHIP.
Number of articles 
Period    
1984-1987                                                      2  
1988-1991                                                      2  
1992-1995                                                      4 
1996-1999                                                    11  
2000-2003                                                      9            
2004-2007                                                    13 
2008-2012                                                    38 
Total                                                             79 
                                                                                     
Location of tumora
Oral cavity                                                    33 
Oral and oro-pharyngeal cavity                    22 
Oral cavity and lip                                          6 
Base of the tongue                                          5 
Oral cavity, oro-pharyngeal cavity and lip     5 
Bottom of the mouth                                      4 
Questionnaire used for HRQOLa
EORTC-QLQb                                              26 
UW-QOLc                                                     22 
PSS-HNd                                                         8 
SF-36e                                                             6 
OHIPf                                                              4 
Othersg                                                          15 
Design
Randomized clinical trial                                 2           
Controlled cohort study                                  10 
Non-controlled cohort study                           29 
Cross-sectional  study                                      34 
Review                                                              4 
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Table  2. Summary of main findings/conclusions from  studies, according to study design and level of evidence.
Randomized clinical trial , with level of evidence 1++ 
       -Changes in the amplitude of the shoulder at six weeks and at six months are associated with changes in the HRQoL 
(54).
Randomized clinical trial, with level of evidence 1+ 
       -The patients who are trained in swallowing obtain better scores on the HRQoL questionnaire than the patients who 
receive no such training (55). 
Controlled cohorts, with level of evidence 2+
    -The average impact on oral HRQoL (OHRQoL) is between 29% and 71% higher (worst OHRQoL) in the patients 
than in the general population (21).
       -In terms of HRQoL, there is no consensus. Some studies report it to be worse than for the control cohort [two times 
as many subjects in the patient cohort affirms having problems in at least one domain (56), or the mean scores in their 
QOL are between 7% and 78% less (57)], whereas other studies find them to be similar (3,45,49,58-60).  
       -Patients who have not received radiotherapy have higher salivary flow rates and significant better results for physical
function, dyspnea, swallowing, social eating, dry mouth and nutritional support (61). 
Non-controlled cohorts, with level of evidence 3
-Better HRQoL before and six months after treatment are predicting factors of greater survival rates (22,36,62).
       -Patients receiving combined treatment (surgery plus radiotherapy and/or chemotherapy) have between 10% and 
28% lower mean scores in HRQoL one year after treatment as opposed to patients who have only surgical treatment 
(15,35,37-39,63), and as much as 54% less in domains such as chewing or dryness of the mouth (36,64).
       -Compared with pre-treatment, the mean scores in HRQoL are between 8% and 31% lower after treatment 
(14,15,17-20,22,65,66). Accordingly, at one year´s time, they are 1% to 20% better (15,17,18,46,65), or scores 
similar to those of pre-treatment are obtained (22,42,43,45,50,67,68).
-Survivors present a significantly reduced overall rating of HRQoL at 1 year follow-up (69).
-Patients with larger tumours and neoplasms in the posterior part of the mouth present poorer quality of life (28).
       -Hyperbaric oxygen therapy may positively influence the long-term radiotherapy sequelae (70). 
       -Older age, eating difficulty, speech difficulty, and depression are significant predictors of orofacial pain 
generated after surgical and radiation therapy (71). 
       -The functional results of soft palate reconstruction are superior to total anterior tongue resection (72). 
Cross-sectional studies, with level of evidence 3
-Patients with a tumor over 4 centimeters in size have average scores in domains such as physical state, cognitive 
function, eating in public or dryness of the mouth that are 11% to 70% lower than patients with smaller tumors 
(4,23,27,31) . 
       -Patients treated with radiotherapy have mean HRQoL scores 8% lower than patients who do not receive 
radiotherapy (34). In domains such as eating or chewing the mean scores may be as much as 29% lower (5,33,34,40). 
       -Chemotherapy, as the initial treatment, combined with radiotherapy or followed by surgery, leads to HRQoL 
scores similar to those obtained with other therapies (surgery followed by radiotherapy) (73,74). 
       -There are authors who find that the type of mandibular resection does not affect HRQoL (33). Others conclude 
that patients with continuity resections have significantly worse values in the HRQoL domains than patients with 
only partial resections (75). Restoration of mandibular continuity after hemimandibulectomy leads to improved 
function and a superior HRQoL in appropriately selected patients (76). 
       -The existence of functional problems is associated with higher levels of depression (4,77,78) and with 
impairment of postoperative HRQoL (79,80). 
       -After treatment of oral cancer and prosthetical rehabilition, men show a significantly higher OHRQoL than 
women (81). 
       -HRQoL is similar between patients treated with selective neck dissection and patients treated with sentinel node 
biopsy procedure (82). 
       -After ablation surgeries, patients reconstructed with free flap have better speech and shoulder functions as well 
as better mood status than patients reconstructed with pectoralis major myocutaneous flap (83). When the 
reconstruction with free flap involves the commissure, HRQoL is lower than other places in the oral cavity (84). 
Patients who have had resections and reconstruction with free anterolateral thigh perforator flaps describe problems 
with chewing, taste and saliva and low scores in the domains handicap, psychological disability and social disability 
(85).
       -Older patients (65 years or over) report better physical and emotional function than younger patients (86,87). 
       -Prevalence of clinical anxiety and depression is within the range 22%-32% in the patients  that underwent major 
surgery (88). 
       -Primary radiation for advanced base of tongue cancer achieves excellent functional status and HRQoL (89-91). 
Total glossectomy produces important problems with eating, speaking and socializing (92,93). 
       - Local reconstructive methods are successful in the management of early oral cancers involving the tongue and 
floor of mouth and patients report satisfactory levels of quality of life (94). 
Reviews, with level of evidence 4 
-With regard to gender, there is no consensus about the existence of differences in HRQoL (2,6). 
      -Regarding age, young patients have a poorer emotional function and a greater risk of psychological stress. Older 
patients have poorer scores in physical function (2,6). 
       -Poorer HRQoL is seen with tumors located in the posterior region, larger tumors and patients who are treated 
with radiotherapy or cervical surgery (2,6,47). 
       -Prospective studies are needed over longer time periods to define the duration of symptoms (95).  
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